Biosilica incorporated 3D porous scaffolds for bone tissue engineering applications.

As a natural and abundant silica mineral, diatomite particles (SiO2-nH2O) have been used in several areas such as filtration, photonics, sound and heat insulation, filler material and drug delivery due to its abundance, inexpensive cost, unique morphology and porous structure. But up to date, diatomite incorporated silica based scaffolds have not been used for bone tissue engineering applications. In the present study, the goal was to combine the useful biomaterial properties of both chitosan and diatomite as biocomposite organic/inorganic biomaterial for bone tissue engineering applications and optimize the silica content of the composites in order to obtain optimum morphological structure, high mechanical properties, enlarged surface area and enhanced cell proliferation. The effect of silica loading on the mechanical, morphological, chemical, and surface properties, wettability and biocompatibility of composite scaffolds were investigated. In addition, in vitro cytotoxicity and cellular activities including cell proliferation, ALP activity and biomineralization were investigated in order to determine biological activity of the composite scaffolds. Diatomite particles lead to enhancement in the water uptake capacity of scaffolds. Chitosan-silica composites exhibited 82-90% porosity. Wet chitosan-silica composite scaffolds exhibited higher compression moduli when compared to pure chitosan scaffold in the range of 67.3-90.1 kPa. Average pore size range of chitosan-diatomite composite scaffolds was obtained as 218-319 μm. In vitro results indicated that chitosan-diatomite composites did not show any cytotoxic effect on 3T3, MG-63 and Saos-2 cell lines. Scaffolds were found to be favorable for osteoblast proliferation. Diatomite incorporation showed promising effects on enhancing ALP activity as well as mineral formation on scaffold surface. Thus, the prepared scaffolds in this study can be considered prospective material for bone tissue engineering applications.

[1]  R. Reis,et al.  Designing biomaterials based on biomineralization of bone , 2010 .

[2]  H. Puchtler,et al.  Chemical Mechanisms of Staining Methods: Von Kossa's Technique: What von Kossa Really Wrote and a Modified Reaction for Selective Demonstration of Inorganic Phosphates , 1985 .

[3]  F. Tihminlioglu,et al.  Diatomite reinforced chitosan composite membrane as potential scaffold for guided bone regeneration. , 2017, Materials science & engineering. C, Materials for biological applications.

[4]  Robert A. Latour,et al.  Biomaterials: Protein-Surface Interactions , 2005 .

[5]  D. Maniglio,et al.  Comparative methods for the evaluation of protein adsorption. , 2009, Macromolecular bioscience.

[6]  Christopher S. Gaddis,et al.  Freestanding microscale 3D polymeric structures with biologically-derived shapes and nanoscale features , 2004 .

[7]  M. Shoichet,et al.  Controlling cell adhesion and degradation of chitosan films by N-acetylation. , 2005, Biomaterials.

[8]  S. Sarvanan,et al.  Biocomposite scaffolds containing chitosan/alginate/nano-silica for bone tissue engineering. , 2013, Colloids and surfaces. B, Biointerfaces.

[9]  J. Donnet,et al.  Elaboration and characterisation of new mesoporous materials from diatomite and charcoal , 2008 .

[10]  Filippo Causa,et al.  Bioactive scaffolds for bone and ligament tissue , 2007, Expert review of medical devices.

[11]  Paul A. Webb,et al.  An Introduction To The Physical Characterization of Materials by Mercury Intrusion Porosimetry with Emphasis On Reduction And Presentation of Experimental Data , 2006 .

[12]  K. Narayanan,et al.  Green synthesis of biogenic metal nanoparticles by terrestrial and aquatic phototrophic and heterotrophic eukaryotes and biocompatible agents. , 2011, Advances in colloid and interface science.

[13]  S. E. Jørgensen.  Biodegradation , 2020, Managing Biological and Ecological Systems.

[14]  Qian Feng,et al.  Effect of inorganic/organic ratio and chemical coupling on the performance of porous silica/chitosan hybrid scaffolds. , 2017, Materials science & engineering. C, Materials for biological applications.

[15]  Y. Wan,et al.  Porous-conductive chitosan scaffolds for tissue engineering II. in vitro and in vivo degradation , 2005, Journal of materials science. Materials in medicine.

[16]  J. Richardson.  EFFECTS 1 , 2022 .

[17]  J. Rungby,et al.  The von Kossa reaction for calcium deposits: silver lactate staining increases sensitivity and reduces background , 1993, The Histochemical Journal.

[18]  M. Thanou,et al.  Biodegradation, biodistribution and toxicity of chitosan. , 2010, Advanced drug delivery reviews.

[19]  Xiaojun Ma,et al.  The enzymatic degradation and swelling properties of chitosan matrices with different degrees of N-acetylation. , 2005, Carbohydrate research.

[20]  M. Uskoković,et al.  Effects of 1α,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: differentiation-stage dependence and modulation by 17-β estradiol , 1996 .

[21]  T. Sen,et al.  Preparation and characterisation of porous silica and silica/titania monoliths for potential use in bone replacement , 2012 .

[22]  R. G. Richards,et al.  In search of an osteoblast cell model for in vitro research. , 2012, European cells & materials.

[23]  Dietmar W Hutmacher,et al.  A comparison of micro CT with other techniques used in the characterization of scaffolds. , 2006, Biomaterials.

[24]  J. Bumgardner,et al.  An overview of chitin or chitosan/nano ceramic composite scaffolds for bone tissue engineering. , 2016, International journal of biological macromolecules.

[25]  M. Textor,et al.  Biodegradable polymer/hydroxyapatite composites: surface analysis and initial attachment of human osteoblasts. , 2001, Journal of biomedical materials research.

[26]  Tsuyoshi Murata,et al.  {m , 1934, ACML.

[27]  Julian R. Jones,et al.  Highly flexible silica/chitosan hybrid scaffolds with oriented pores for tissue regeneration. , 2015, Journal of materials chemistry. B.

[28]  S. Nair,et al.  Novel chitin/nanosilica composite scaffolds for bone tissue engineering applications. , 2009, International journal of biological macromolecules.

[29]  N. Charoenphandhu,et al.  In vitro study of the SBF and osteoblast-like cells on hydroxyapatite/chitosan–silica nanocomposite , 2011 .

[30]  Changsheng Liu,et al.  Biomimetic porous scaffolds for bone tissue engineering , 2014 .

[31]  Amit Bandyopadhyay,et al.  Recent advances in bone tissue engineering scaffolds. , 2012, Trends in biotechnology.

[32]  G. Kakali,et al.  Properties and hydration of blended cements with calcareous diatomite , 2006 .

[33]  K. Anselme,et al.  Osteoblast adhesion on biomaterials. , 2000, Biomaterials.

[34]  F. Peyrin,et al.  Evaluation of bone scaffolds by micro-CT , 2011, Osteoporosis International.

[35]  M. Fathi,et al.  Characterization of silicon-substituted hydroxyapatite powders synthesized by a wet precipitation method , 2014 .

[36]  Dietmar Werner Hutmacher,et al.  State of the art and future directions of scaffold‐based bone engineering from a biomaterials perspective , 2007, Journal of tissue engineering and regenerative medicine.

[37]  Miqin Zhang,et al.  Chitosan-based scaffolds for bone tissue engineering. , 2014, Journal of materials chemistry. B.

[38]  Christian Hamm,et al.  Engineering and medical applications of diatoms. , 2005, Journal of nanoscience and nanotechnology.

[39]  M. McKee,et al.  In vitro osteogenesis assays: influence of the primary cell source on alkaline phosphatase activity and mineralization. , 2009, Pathologie-biologie.

[40]  R. Gordon,et al.  Beyond micromachining: the potential of diatoms. , 1999, Trends in biotechnology.

[41]  N. Vilaboa,et al.  In search of representative models of human bone-forming cells for cytocompatibility studies. , 2011, Acta biomaterialia.

[42]  S. Milz,et al.  Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts. , 2004, Anticancer research.

[43]  S. Dedhar,et al.  An adhesion variant of the MG-63 osteosarcoma cell line displays an osteoblast-like phenotype. , 1988, Ciba Foundation symposium.

[44]  D. Kaplan,et al.  Porosity of 3D biomaterial scaffolds and osteogenesis. , 2005, Biomaterials.

[45]  C. Özgür,et al.  Purification of diatomite powder by acid leaching for use in fabrication of porous ceramics , 2009 .

[46]  Ce Wang,et al.  Diatom‐Templated Synthesis of Ordered Meso/Macroporous Hierarchical Materials , 2006 .

[47]  Lyndon Jones,et al.  The Impact of Contact Angle on the Biocompatibility of Biomaterials , 2010, Optometry and vision science : official publication of the American Academy of Optometry.

[48]  H. Sussman,et al.  Characterization of a human osteoblastic osteosarcoma cell line (SAOS‐2) with high bone alkaline phosphatase activity , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[49]  Ayako Oyane,et al.  Preparation and assessment of revised simulated body fluids. , 2003, Journal of biomedical materials research. Part A.

[50]  D. Maniglio,et al.  Processing and characterization of diatom nanoparticles and microparticles as potential source of silicon for bone tissue engineering. , 2016, Materials science & engineering. C, Materials for biological applications.

[51]  David Hui,et al.  A critical review on polymer-based bio-engineered materials for scaffold development , 2007 .

[52]  H. Elden,et al.  Diatomite: Its Characterization, Modifications and Applications , 2010 .

[53]  C. Bowler,et al.  Molecular insights into the novel aspects of diatom biology , 2001, Cellular and Molecular Life Sciences CMLS.

[54]  H. Giesche,et al.  Mercury Porosimetry: A General (Practical) Overview , 2006 .

[55]  P. Amorós,et al.  Biomimetic chitosan-mediated synthesis in heterogeneous phase of bulk and mesoporous silica nanoparticles. , 2009, Chemical communications.

[56]  M. Khraisheh,et al.  Remediation of wastewater containing heavy metals using raw and modified diatomite , 2004 .

[57]  M. Gowen,et al.  Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype? , 1994, Bone.

[58]  John P. Smol,et al.  The diatoms: applications for the environmental and earth sciences , 2012 .

[59]  D. B. Evans,et al.  PCR phenotyping of cytokines, growth factors and their receptors and bone matrix proteins in human osteoblast-like cell lines. , 1996, Bone.

[60]  Yu Wang,et al.  Preparation of biosilica structures from frustules of diatoms and their applications: current state and perspectives , 2012, Applied Microbiology and Biotechnology.

[61]  R. Reis,et al.  Silicon–hydroxyapatite bioactive coatings (Si–HA) from diatomaceous earth and silica. Study of adhesion and proliferation of osteoblast-like cells , 2009, Journal of materials science. Materials in medicine.

[62]  A. Gaharwar,et al.  Development of Biomedical Polymer-Silicate Nanocomposites: A Materials Science Perspective , 2010, Materials.